z-logo
open-access-imgOpen Access
The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.
Author(s) -
E. Byrd Quinlivan
Publication year - 2020
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/v5qc-4h03
Subject(s) - long terminal repeat , virology , enhancer , terminal (telecommunication) , human immunodeficiency virus (hiv) , epstein–barr virus , gene , biology , virus , genetics , gene expression , computer science , telecommunications

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom